TP53 and neoplasm: The potential antitumor effects of all synthesized compounds were screened in three human tumor cell lines (A375-C5, MCF-7, and HCT116), and the most promising compounds were selected, aiming to evaluate the mechanism of action related with their cytotoxicity, namely, regarding the p53–MDM2 interaction inhibition, apoptosis induction, and mitotic arrest.